REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Elixym Biopharmaceutical Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Elixym Biopharmaceutical Sas Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Elixym Biopharmaceutical Sas is an enterprise located in Colombia, with the main office in Bogota D.C.. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on October 05, 2012. 1 (2024) employees currently work for Elixym Biopharmaceutical Sas. The latest financial highlights indicate a net sales revenue increase of 15.66% in 2023. Over the same period, its total assets grew by 67.62%.

Headquarters
Calle 124 # 45 15 Oficina 301
Bogota D.C.; Bogota D.C; Postal Code: 1015

Contact Details: Purchase the Elixym Biopharmaceutical Sas report to view the information.

Basic Information
Total Employees:
Purchase the Elixym Biopharmaceutical Sas report to view the information.
Outstanding Shares:
Purchase the Elixym Biopharmaceutical Sas report to view the information.
Incorporation Date:
October 05, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Elixym Biopharmaceutical Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
15.66%▲
Total operating revenue
15.66%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
67.62%▲
Total equity
3.8%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.11%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo